Skip to main content
. 2020 Jan 14;13:1393. doi: 10.3389/fnins.2019.01393

FIGURE 2.

FIGURE 2

ShK and Kv1.3 blocking polypeptides as potential therapeutic agents for neuroinflammatory diseases. ShK and Kv1.3 toxins might be used to treat multiple sclerosis, and other neuroinflammatory disorders via inhibiting Kv1.3 expressed in T lymphocytes as well as microglial cells.